tirzepatide off label use is a novel medication that the FDA has approved for treating type 2 diabetes mellitus. Due to its potent weight loss properties, Tirzepatide can be used off-label for treating obesity. The Lilly Updates Open Letter Regarding

They act as signalling molecules that send messages between cells and tissues to perform specific biological functions such as hormone release, tissue repair, fat metabolism, and muscle growth

Treatment decisions should always be made in consultation with a qualified healthcare provider based on individual medical needs and health history.

Zepbound and Mounjaro are the exact same medication, tirzepatide, with the same strength unlike Ozempic and Wegovy, the Novo Nordisk competitors marketed for type 2 diabetes and weight loss respectively, which have different strengths

Month 1: Starting Retatrutide (Weeks 1-4) The first month is about establishing habits and preventing problems before they start

Well, its finally here

With Ozempic, you can expect improved appetite control and better metabolic function, leading to a more sustainable and healthier weight loss experience